COVID-19 vaccine candidate MVA-CoV2-S confers full protection against SARS-CoV-2 neuroinvasion in humanized mice, preventing brain viral replication and the associated neuronal and vascular damage, even after reinfection, according to a paper published in Nature Neuroscience
nature.comSubmitted by MistWeaver80 t3_10fzltv in science
Radiant_Platypus6862 t1_j50ibzg wrote
This is really promising. The neurological effects of my covid infection back in 2020 have not had any improvement, whereas the cardiopulmonary effects have improved somewhat in the last few months for me (finally). It’s terrifying, to be completely honest, and the other recent study that revealed that they have found the virus in people’s brains on autopsies didn’t quell my anxiety. I’ve really worried about the long term neurological implications of allowing covid to run rampant because the infections are mostly “mild” now. Hopefully this is a solution to that.